Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

The food industry is facing a Perfect Storm - assaults on ultra-processed foods; warning labels; and the rise of GLP-1 drug ...

A new weight-loss drug policy? The latest class of weight-loss drugs - also known as GLP-1 agonists - are "the most potent w ...

Dr. Christina Li specializes in minimally invasive weight loss surgery at LifeBridge Health's Northwest Hospital in ...

Kennedy is nominated to lead the Department of Health and Human Services, a position that would give him enormous control ...

The conversation surrounding healthcare reform has intensified in recent years, revealing deep divides in how we view ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

The skyrocketing popularity of weight-loss drugs like Wegovy, one of a class of drugs called GLP-1s, is fast becoming a state ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...